Top Markets
Coin of the day
Decision Diagnostics Corp. Decision Diagnostics Corp.

Decision Diagnostics Corp.

DECN
Classement en actions #41200
Decision Diagnostics Corp. (DECN), founded in 2000 and based in Westlake... Decision Diagnostics Corp. (DECN), founded in 2000 and based in Westlake Village, California, specializes in developing electronic medical record (EMR) technologies primarily optimized for smartphones. The company provides a wide array of offerings, including both regulated and unregulated diagnostic solutions, as well as home-use testing products for individuals managing chronic illnesses. They also facilitate direct-to-patient logistics for diabetes programs and concentrate on creating mobile-centric e-health products and associated technological innovations. A key part of their product line involves glucose monitoring. This includes the GenUltimate! glucose test strips, classified as a Class II medical device for personal at-home human use. For animal health, they manufacture PetSure! glucose test strips, designed to measure glucose levels in dogs and cats and compatible with legacy Zoetis AlphaTrak glucometers. Additionally, they offer the proprietary GenUltimate! 4Pets Glucose system, which combines the GenUltimate! 4Pets strip with the Avantage meter, enabling glucose testing for canine, feline, and equine patients. Further glucose strip options include GenUltimate! Sure and GenUltimate! Precis. Beyond product development, Decision Diagnostics actively acquires and maintains a portfolio of intellectual property, spanning patents, trademarks, and specialized manufacturing equipment. Their software solutions include MD@Hand, a comprehensive management system for both inpatient and outpatient care; Practice Probe, a data mining utility designed to extract information from physician practice management systems; and ResidenceWare, a residential management system that streamlines communication between commercial or residential real estate managers and their tenants through networked applications. Ultimately, their EMR innovations provide crucial tools for physicians directly at the point of patient care. The company was originally known as InstaCare Corp. before officially changing its name to Decision Diagnostics Corp. in November 2011.
Prix de l'action
$0.0001
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$35.79K
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Decision Diagnostics Corp. (DECN)

Catégorie

Le prix DECN avec la capitalisation boursière de B
Decision Diagnostics Corp. Decision Diagnostics Corp.
DECN
$0.0001
Capitalisation boursière de Decision Diagnostics Corp.(DECN)
Capitalisation boursière: $35.79K
En August 2026, Decision Diagnostics Corp. a une capitalisation boursière de $35.79K. Cela fait de Decision Diagnostics Corp. la 41200th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Decision Diagnostics Corp. du 2002 au 2026
DECN par rapport au top 5 des plus populaires stocks
Prix pour DECN L’actif B La capitalisation boursière de B Résultats
Decision Diagnostics Corp. Decision Diagnostics Corp.
$15,042.78 $35.79K
$5.383T +15,042,779,289.16%
Decision Diagnostics Corp. Decision Diagnostics Corp.
$12,360.33 $35.79K
$4.423T +12,360,329,639.12%
Decision Diagnostics Corp. Decision Diagnostics Corp.
$11,625.37 $35.79K
$4.160T +11,625,364,974.14%
Decision Diagnostics Corp. Decision Diagnostics Corp.
$10,236.46 $35.79K
$3.663T +10,236,456,817.32%
Decision Diagnostics Corp. Decision Diagnostics Corp.
$8,078.99 $35.79K
$2.891T +8,078,991,699.82%